Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes ...

Cell therapy manufacturers Charles River and ElevateBio are named as inaugural membersANN ARBOR, Mich., Dec. 9, 2025 /PRNewswire/ -- Akadeum Life ...

Hutchmed announces expanded coverage on National Reimbursement Drug List and inclusion in the first Commercial Insurance Drug List in China: Hong Kong, Shanghai Tuesday, December ...

Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising new biomarker ...

Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising new biomarker of "complicated" mild- to severe-pediatric traumatic brain injury, or TBI.

Five LMU researchers have been awarded Consolidator Grants by the European Research Council. Their projects deal with climate change, strokes, ...

P atients with previously incurable cancer are seeing incredible results thanks to a pioneering new treatment that has just ...

Scientists anticipate a future where transgender people could create their own gender-affirming hormones and even produce ...

Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...

Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of ...